Dr Pascale Tomasini
- Specialty
- Oncologist, lung expert
- Hospital
- AP-HM Hôpital Nord (Marseille)
- Latest articles
-
- The evolving role of Hospital Oncology Pharmacists (HOPs) in assessing therapeutic innovations and managing toxicities in cancer care. (Jan 1, 2026)
- Amivantamab Plus Lazertinib in Atypical EGFR-Mutated Advanced Non-Small Cell Lung Cancer: Results From CHRYSALIS-2. (Jan 1, 2026)
- Patient-Relevant Outcomes From the Phase III MARIPOSA-2 Trial: Amivantamab-Chemotherapy Versus Chemotherapy in EGFR-Mutant Advanced Non-Small-Cell Lung Cancer Following Disease Progression on Osimertinib. (Dec 20, 2025)
- Is adjuvant chemotherapy beneficial in NSCLC patients over 75? Insights from a retrospective analysis. (Oct 1, 2025)
- Enhanced Versus Standard Dermatologic Management With Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC: The COCOON Global Randomized Controlled Trial. (Oct 1, 2025)